We've seen it before. Volume came in late 2020 and SP went up and up. The volume has not come back, but was are a day closer to that day when it does go back up.
Fundamentally, the company is succeeding in its business plan.
- Forums
- ASX - By Stock
- Ann: FDA grants RPDD to paxaliaib for AT/RT
We've seen it before. Volume came in late 2020 and SP went up...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)